105例恶性卵巢生殖细胞肿瘤幸存者的生育结局:一项多中心研究
该多中心研究基于东海卵巢肿瘤研究组数据库(1986年至2016年)纳入110例接受保留生育治疗的恶性卵巢生殖细胞肿瘤患者,最终分析105例,中位随访10.4年。附加调查显示45例有生育意愿者中42例妊娠,共65次妊娠、40例幸存者分娩56名婴儿。作者认为保留生育治疗后的生育结局是乐观的。
要点
- 接受保留生育治疗的恶性卵巢生殖细胞肿瘤幸存者中,有生育意愿者多数可妊娠并分娩。
- 45例有生育意愿的患者中42例妊娠,共65次妊娠,40例幸存者分娩56名婴儿。
- 中位随访10.4年,105例最终纳入分析。
核心结论
- 恶性卵巢生殖细胞肿瘤幸存者在保留生育治疗后的生育结局是乐观的,若有生育意愿可以妊娠并分娩。
研究设计与样本
- 使用东海卵巢肿瘤研究组数据库,评估1986年至2016年数据,选取年龄小于40岁且接受保留生育治疗的恶性卵巢生殖细胞肿瘤患者。
- 向注册机构发放生育结局问卷,收集年龄、发病日期、手术方式、化疗方案、肿瘤类型、国际妇产科联盟分期、生存结局及时间、妊娠和分娩次数、婚姻状况、生育意愿、妊娠方式、分娩孕周、婴儿出生体重、产科并发症及保留生育治疗后月经状态等数据。
- 共识别110例接受保留生育治疗的恶性卵巢生殖细胞肿瘤患者,中位随访10.4年,排除5例因复发治疗后死亡或丧失生育能力者,最终纳入105例。
主要发现
- 附加调查显示,45例有生育意愿的患者中42例妊娠。
- 总妊娠次数为65次,40例恶性卵巢生殖细胞肿瘤幸存者分娩56名婴儿。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Malignant ovarian germ cell tumors usually occur in young women. Until the 1970s, before establishment of systemic chemotherapy, malignant ovarian germ cell tumors had a very poor prognosis. Recently, prognosis has improved, and fertility-sparing treatment is being adopted in patients who desire to become pregnant. However, the number of malignant ovarian germ cell tumor survivors who actually became pregnant remains unknown. OBJECTIVE: The present study aimed to clarify the reproductive outcomes in malignant ovarian germ cell tumor survivors by using data from a multicenter database and an additional survey on reproductive outcomes. STUDY DESIGN: The study used the Tokai Ovarian Tumor Study Group database on ovarian cancer patients. We assessed the database from 1986 through 2016 and selected malignant ovarian germ cell tumor patients <40 years of age who received fertility-sparing treatment. Questionnaires on reproductive outcomes were sent to the registered facilities. The following data were collected and used in this study: age, date of onset, surgical procedure, chemotherapy regimen, tumor type, International Federation of Gynecology and Obstetrics stage, survival outcome and period, number of pregnancies and childbirths, marital status, childbearing desire, method of pregnancy, gestational weeks at delivery, birthweight of the baby, obstetric complications, and menstrual status after fertility-sparing treatment. RESULTS: A total of 110 malignant ovarian germ cell tumor patients who received fertility-sparing treatment were identified. The median follow-up period was 10.4 years. Five patients were excluded because of death or loss of fertility after treatment for recurrence. Thus, 105 patients were finally included. The additional survey revealed that 42 of 45 patients who desired childbirth became pregnant. The total number of pregnancies was 65, and 56 babies were born to 40 malignant ovarian germ cell tumor survivors. CONCLUSION: The reproductive outcomes of malignant ovarian germ cell tumor survivor are promising with fertility-sparing treatment. Malignant ovarian germ cell tumor survivors can become pregnant and give birth if they desire.
引用
- Tamauchi S, Kajiyama H, Yoshihara M, et al. Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study. Am J Obstet Gynecol. 2018. PMID: 30086295. doi:10.1016/j.ajog.2018.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。